Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115273) titled 'The influence of remimazolam and propofol on heart rate variability in patients with sepsis' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Qilu Hospital of Shandong University (Qingdao)
Condition:
Sepsis
Intervention:
Remimazolam group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Remimazolam group:50;Propofol group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=298614
Published by HT Digital Content Services with permission from Health D...